{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:38:09Z","timestamp":1787755089527,"version":"build-2784847793"},"reference-count":69,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Academic Forensic Pathology"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>Fatty liver is a common finding in clinical practice and at autopsy. It is most commonly seen associated with alcohol abuse and in non-alcoholic fatty liver disease (NAFLD). It may also be seen in many other conditions in both adults and children. It is now recognized that NAFLD, like alcoholic liver disease, may lead to end stage liver disease. Nonalcoholic fatty liver disease is associated with increased mortality from other disorders, particularly cardiovascular diseases. Fatty liver may be seen in many conditions that concern autopsy pathologists, including drug toxicity, anorexia, hepatic ischemia, and heatstroke. In infants, steatosis is common in sudden unexpected deaths. Fatty liver has been associated with sudden death and this review examines the pathology and role of fatty liver in sudden death. Acad Forensic Pathol. 2018 8(2): 296-310<\/jats:p>","DOI":"10.1177\/1925362118782061","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T10:46:01Z","timestamp":1528281961000},"page":"296-310","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Fatty Liver and the Forensic Pathologist"],"prefix":"10.1177","volume":"8","author":[{"given":"Christopher M.","family":"Milroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,6,6]]},"reference":[{"key":"bibr1-1925362118782061","doi-asserted-by":"crossref","unstructured":"Tiniakos DG, Anstee QM, Burt AD. MacSween\u2019s pathology of the liver. 7th ed. Philadephia: Elsevier; c2018. Chapter 5, Fatty liver disease; p. 308\u201371.","DOI":"10.1016\/B978-0-7020-6697-9.00005-4"},{"key":"bibr2-1925362118782061","doi-asserted-by":"crossref","unstructured":"MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis. 1986 8; 6(3):221\u201332. PMID: 3022386. https:\/\/doi.org\/10.1055\/s-2008-1040605.","DOI":"10.1055\/s-2008-1040605"},{"key":"bibr3-1925362118782061","doi-asserted-by":"crossref","unstructured":"Syn WK, Teaberry V, Choi SS, Diehl AM, Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis. 2009 8; 29(2):200\u201310. PMID: 19387919. PMCID: PMC3644873. https:\/\/doi.org\/10.1055\/s-0029-1214375.","DOI":"10.1055\/s-0029-1214375"},{"key":"bibr4-1925362118782061","doi-asserted-by":"crossref","unstructured":"Tannapfel A, Denk H, Dienes HP, Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch. 2011 8; 458(5):511\u201323. PMID: 21442288. https:\/\/doi.org\/10.1007\/s00428-011-1066-1.","DOI":"10.1007\/s00428-011-1066-1"},{"key":"bibr5-1925362118782061","doi-asserted-by":"crossref","unstructured":"Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol. 2006 8-11; 23(3-4):149\u201360. PMID: 17355088. https:\/\/doi.org\/10.1053\/j.semdp.2006.11.002.","DOI":"10.1053\/j.semdp.2006.11.002"},{"key":"bibr6-1925362118782061","doi-asserted-by":"crossref","unstructured":"Edmondson HA, Peters RL, Frankel HH, Borowsky S. The early stage of liver injury in the alcoholic. Medicine (Baltimore). 1967 3; 46(2):119\u201329. PMID: 6027458. https:\/\/doi.org\/10.1097\/00005792-196703000-00006.","DOI":"10.1097\/00005792-196703000-00006"},{"key":"bibr7-1925362118782061","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(83)90131-2"},{"key":"bibr8-1925362118782061","doi-asserted-by":"crossref","unstructured":"Bhathal PS, Wilkinson P, Clifton S, The spectrum of liver diseases in alcoholism. Aust N Z J Med. 1975 2; 5(1):49\u201357. PMID: 1057913. https:\/\/doi.org\/10.1111\/j.1445-5994.1975.tb03255.x.","DOI":"10.1111\/j.1445-5994.1975.tb03255.x"},{"key":"bibr9-1925362118782061","doi-asserted-by":"crossref","unstructured":"Edmondson HA, Peters RL, Reynolds TB, Kuzma OT. Sclerosing hyaline necrosis of the liver in the chronic alcoholic. A recognizable clinical syndrome. Ann Intern Med. 1963 11; 59:646\u201373. PMID: 14082718. https:\/\/doi.org\/10.7326\/0003-4819-59-5-646.","DOI":"10.7326\/0003-4819-59-5-646"},{"key":"bibr10-1925362118782061","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(82)80007-3"},{"key":"bibr11-1925362118782061","doi-asserted-by":"crossref","unstructured":"Burt AD, MacSween RN. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol. 1986 1; 39(1):63\u20137. PMID: 3950032. PMCID: PMC499614. https:\/\/doi.org\/10.1136\/jcp.39.1.63.","DOI":"10.1136\/jcp.39.1.63"},{"key":"bibr12-1925362118782061","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(82)80006-1"},{"key":"bibr13-1925362118782061","doi-asserted-by":"crossref","unstructured":"Worner TM, Lieber CS. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA. 1985 8 2; 254(5):627\u201330. PMID: 4009897. https:\/\/doi.org\/10.1001\/jama.254.5.627.","DOI":"10.1001\/jama.254.5.627"},{"key":"bibr14-1925362118782061","doi-asserted-by":"crossref","unstructured":"Fauerholdt L, Schlichting P, Christensen E, et al. Conversion of micronodular cirrhosis into macronodular cirrhosis. Hepatology. 1983 Nov-Dec; 3(6):928\u201331. PMID: 6629323. https:\/\/doi.org\/10.1002\/hep.1840030607.","DOI":"10.1002\/hep.1840030607"},{"key":"bibr15-1925362118782061","doi-asserted-by":"crossref","unstructured":"Argo CK, Henry ZH, Caldwell SH. Schiff\u2019s diseases of the liver. 12th ed. Hoboken (NJ): John Wiley and Sons; c2018. Chapter 32, Nonalcoholic fatty liver disease; p. 867\u2013910.","DOI":"10.1002\/9781119251316.ch32"},{"key":"bibr16-1925362118782061","doi-asserted-by":"crossref","unstructured":"Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010 4; 7(4):195\u2013203. PMID: 20195271. https:\/\/doi.org\/10.1038\/nrgastro.2010.21.","DOI":"10.1038\/nrgastro.2010.21"},{"key":"bibr17-1925362118782061","doi-asserted-by":"crossref","unstructured":"Thuluvath PJ, Kantsevoy S, Thuluvath AJ, Savva Y. Is cryptogenic cirrhosis different from NASH cirrhosis? J Hepatol. 2018 3; 68(3):519\u2013525. PMID: 29162389. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.018.","DOI":"10.1016\/j.jhep.2017.11.018"},{"key":"bibr18-1925362118782061","doi-asserted-by":"crossref","unstructured":"Becker U, Deis A, S\u00f8rensen TI, Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996 8; 23(5):1025\u20139. PMID: 8621128. https:\/\/doi.org\/10.1053\/jhep.1996.v23.pm0008621128.","DOI":"10.1053\/jhep.1996.v23.pm0008621128"},{"key":"bibr19-1925362118782061","doi-asserted-by":"crossref","unstructured":"Hayashi PH, Harrison SA, Torgerson S, Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Am J Gastroenterol. 2004 1; 99(1):76\u201381. PMID: 14687145. https:\/\/doi.org\/10.1046\/j.1572-0241.2003.04013.x.","DOI":"10.1046\/j.1572-0241.2003.04013.x"},{"key":"bibr20-1925362118782061","doi-asserted-by":"crossref","unstructured":"Pinto HC, Baptista A, Camilo ME, Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 1996 1; 41(1):172\u20139. PMID: 8565753. https:\/\/doi.org\/10.1007\/bf02208601.","DOI":"10.1007\/BF02208601"},{"key":"bibr21-1925362118782061","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016 7; 64(1):73\u201384. PMID: 27607365. https:\/\/doi.org\/10.1002\/hep.28431.","DOI":"10.1002\/hep.28431"},{"key":"bibr22-1925362118782061","doi-asserted-by":"crossref","unstructured":"Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999 12; 30(6):1356\u201362. PMID: 10573511. https:\/\/doi.org\/10.1002\/hep.510300604.","DOI":"10.1002\/hep.510300604"},{"key":"bibr23-1925362118782061","doi-asserted-by":"crossref","unstructured":"Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006 10; 45(4):600\u20136. PMID: 16899321. https:\/\/doi.org\/10.1016\/j.jhep.2006.06.013.","DOI":"10.1016\/j.jhep.2006.06.013"},{"key":"bibr24-1925362118782061","doi-asserted-by":"crossref","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 6; 41(6):1313\u201321. PMID: 15915461. https:\/\/doi.org\/10.1002\/hep.20701.","DOI":"10.1002\/hep.20701"},{"key":"bibr25-1925362118782061","doi-asserted-by":"crossref","unstructured":"Bellentani S, Saccoccio G, Masutti F, Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000 1 18; 132(2):112\u20137. PMID: 10644271. https:\/\/doi.org\/10.7326\/0003-4819-132-2-200001180-00004.","DOI":"10.7326\/0003-4819-132-2-200001180-00004"},{"key":"bibr26-1925362118782061","doi-asserted-by":"crossref","unstructured":"Park SH, Kim BI, Yun JW, Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004 6; 19(6):694\u20138. PMID: 15151626. https:\/\/doi.org\/10.1111\/j.1440-1746.2004.03362.x.","DOI":"10.1111\/j.1440-1746.2004.03362.x"},{"key":"bibr27-1925362118782061","doi-asserted-by":"crossref","unstructured":"Omagari K, Kadokawa Y, Masuda J, Fatty Liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol. 2002 10; 17(10):1098\u2013105. PMID 12201871. https:\/\/doi.org\/10.1046\/j.1440-1746.2002.02846.x.","DOI":"10.1046\/j.1440-1746.2002.02846.x"},{"issue":"10","key":"bibr28-1925362118782061","first-page":"1349","volume":"85","author":"Silverman JF","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"bibr29-1925362118782061","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Otgonsuren M, Henry L, Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology. 2015 12; 62(6):1723\u201330. PMID: 26274335. https:\/\/doi.org\/10.1002\/hep.28123.","DOI":"10.1002\/hep.28123"},{"key":"bibr30-1925362118782061","doi-asserted-by":"crossref","unstructured":"Ertle J, Dech\u00eane A, Sowa JP, Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer. 2011 5 15; 128(10):2436\u201343. PMID: 21128245. https:\/\/doi.org\/10.1002\/ijc.25797.","DOI":"10.1002\/ijc.25797"},{"key":"bibr31-1925362118782061","doi-asserted-by":"crossref","unstructured":"Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012 6; 56(6):1384\u201391. PMID: 22326465. https:\/\/doi.org\/10.1016\/j.jhep.2011.10.027.","DOI":"10.1016\/j.jhep.2011.10.027"},{"key":"bibr32-1925362118782061","doi-asserted-by":"crossref","unstructured":"Solis-Herruzo JA, P\u00e9rez-Carreras M, Rivas E, Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C. Am J Gastroenterol. 2005 8; 100(5): 1091\u20138. PMID: 15842583. https:\/\/doi.org\/10.1111\/j.1572-0241.2005.41059.x.","DOI":"10.1111\/j.1572-0241.2005.41059.x"},{"key":"bibr33-1925362118782061","doi-asserted-by":"crossref","unstructured":"Sorrentino P, Terracciano L, D\u2019Angelo S, Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis. J Gastroenterol. 2010 10; 45(10):1053\u201362. PMID: 20393861. https:\/\/doi.org\/10.1007\/s00535-010-0249-x.","DOI":"10.1007\/s00535-010-0249-x"},{"key":"bibr34-1925362118782061","doi-asserted-by":"crossref","unstructured":"Weston SR, Leyden W, Murphy R, Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology. 2005 2; 41(2):372\u20139. PMID: 15723436. https:\/\/doi.org\/10.1002\/hep.20554.","DOI":"10.1002\/hep.20554"},{"key":"bibr35-1925362118782061","doi-asserted-by":"crossref","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004 12; 40(6):1387\u201395. PMID: 15565570. https:\/\/doi.org\/10.1002\/hep.20466.","DOI":"10.1002\/hep.20466"},{"key":"bibr36-1925362118782061","doi-asserted-by":"crossref","unstructured":"Schwimmer JB, McGreal N, Deutsch R, Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics. 2005 8; 115(5): e561\u20135. PMID: 15867021. https:\/\/doi.org\/10.1542\/peds.2004-1832.","DOI":"10.1542\/peds.2004-1832"},{"key":"bibr37-1925362118782061","doi-asserted-by":"crossref","unstructured":"Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (Silver Spring). 2007 11; 15(11):2817\u201324. PMID: 18070773. https:\/\/doi.org\/10.1038\/oby.2007.334.","DOI":"10.1038\/oby.2007.334"},{"key":"bibr38-1925362118782061","doi-asserted-by":"crossref","unstructured":"Wang J, Thornton JC, Russell M, Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr. 1994 7; 60(1): 23\u20138. PMID: 8017333. https:\/\/doi.org\/10.1093\/ajcn\/60.1.23.","DOI":"10.1093\/ajcn\/60.1.23"},{"key":"bibr39-1925362118782061","doi-asserted-by":"crossref","unstructured":"Heo M, Faith MS, Pietrobelli A, Heymsfield SB. Percentage of body fat cutoffs by sex, age, and race-ethnicity in the US adult population from NHANES 1999\u20132004. Am J Clin Nutr. 2012 3; 95(3):594\u2013602. PMID: 22301924. https:\/\/doi.org\/10.3945\/ajcn.111.025171.","DOI":"10.3945\/ajcn.111.025171"},{"key":"bibr40-1925362118782061","doi-asserted-by":"crossref","unstructured":"Anstee QM, Day CP. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol. 2013 11; 10(11):645\u201355. PMID: 24061205. https:\/\/doi.org\/10.1038\/nrgastro.2013.182.","DOI":"10.1038\/nrgastro.2013.182"},{"key":"bibr41-1925362118782061","doi-asserted-by":"crossref","unstructured":"Rinella ME, Sanyal AJ. NAFLD in 2014: genetics, diagnostics and therapeutic advances in NAFLD. Nat Rev Gastroenterol Hepatol. 2015 2; 12(2):65\u20136. PMID: 25560844. PMCID: PMC4984668. https:\/\/doi.org\/10.1038\/nrgastro.2014.232.","DOI":"10.1038\/nrgastro.2014.232"},{"key":"bibr42-1925362118782061","doi-asserted-by":"crossref","unstructured":"Anstee QM, Day CP. The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2. Semin Liver Dis. 2015 8; 35(3):270\u201390. PMID: 26378644. https:\/\/doi.org\/10.1055\/s-0035-1562947.","DOI":"10.1055\/s-0035-1562947"},{"key":"bibr43-1925362118782061","doi-asserted-by":"crossref","unstructured":"Dongiovanni P, Valenti L. Genetics of nonalcoholic fatty liver disease. Metabolism. 2016 8; 65(8):1026\u201337. PMID: 26409295. https:\/\/doi.org\/10.1016\/j.metabol.2015.08.018.","DOI":"10.1016\/j.metabol.2015.08.018"},{"key":"bibr44-1925362118782061","doi-asserted-by":"crossref","unstructured":"Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001 9; 121(3):710\u201323. PMID: 11522755. https:\/\/doi.org\/10.1053\/gast.2001.27126.","DOI":"10.1053\/gast.2001.27126"},{"key":"bibr45-1925362118782061","doi-asserted-by":"crossref","unstructured":"Adams LA, Lymp JF, Sauver JS, The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005 7; 129(1):113\u201321. PMID: 16012941. https:\/\/doi.org\/10.1053\/j.gastro.2005.04.014.","DOI":"10.1053\/j.gastro.2005.04.014"},{"key":"bibr46-1925362118782061","doi-asserted-by":"crossref","unstructured":"Ekstedt M, Franz\u00e9n LE, Mathiesen UL, Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006 10; 44(4):865\u201373. PMID: 17006923. https:\/\/doi.org\/10.1002\/hep.21327.","DOI":"10.1002\/hep.21327"},{"key":"bibr47-1925362118782061","doi-asserted-by":"crossref","unstructured":"Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008 10; 49(4):608\u201312. PMID: 18682312. https:\/\/doi.org\/10.1016\/j.jhep.2008.06.018.","DOI":"10.1016\/j.jhep.2008.06.018"},{"key":"bibr48-1925362118782061","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Stepanova M, Rafiq N, Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011 6; 53(6):1874\u201382. PMID: 21360720. https:\/\/doi.org\/10.1002\/hep.24268.","DOI":"10.1002\/hep.24268"},{"key":"bibr49-1925362118782061","doi-asserted-by":"crossref","unstructured":"Stepanova M, Rafiq N, Makhlouf H, Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2013 10; 58(10): 3017\u201323. PMID: 23775317. https:\/\/doi.org\/10.1007\/s10620-013-2743-5.","DOI":"10.1007\/s10620-013-2743-5"},{"key":"bibr50-1925362118782061","doi-asserted-by":"crossref","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015 8; 61(5):1547\u201354. PMID: 25125077. https:\/\/doi.org\/10.1002\/hep.27368.","DOI":"10.1002\/hep.27368"},{"key":"bibr51-1925362118782061","doi-asserted-by":"crossref","unstructured":"Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990 11; 12(5):1106\u201310. PMID: 2227807. https:\/\/doi.org\/10.1002\/hep.1840120505.","DOI":"10.1002\/hep.1840120505"},{"key":"bibr52-1925362118782061","doi-asserted-by":"crossref","unstructured":"Zois CD, Baltayiannis GH, Bekiari A, Steatosis and steatohepatitis in postmortem material from Northwestern Greece. World J Gastroenterol. 2010 8 21; 16(31):3944\u20139. PMID: 20712056. PMCID: PMC2923769. https:\/\/doi.org\/10.3748\/wjg.v16.i31.3944.","DOI":"10.3748\/wjg.v16.i31.3944"},{"key":"bibr53-1925362118782061","doi-asserted-by":"crossref","unstructured":"Lal A, Parai JL, Milroy CM. Liver pathology in first presentation diabetic ketoacidosis at autopsy. Acad Forensic Pathol. 2016 6; 6(2): 271\u201380. https:\/\/doi.org\/10.23907\/2016.028.","DOI":"10.23907\/2016.028"},{"key":"bibr54-1925362118782061","doi-asserted-by":"crossref","unstructured":"Randall B. Fatty liver and sudden death. A review. Hum Pathol. 1980 3; 11(2):147\u201353. PMID: 6105125. https:\/\/doi.org\/10.1016\/s0046-8177(80)80133-x.","DOI":"10.1016\/S0046-8177(80)80133-X"},{"key":"bibr55-1925362118782061","doi-asserted-by":"crossref","unstructured":"Kramer K, Kuller L, Fisher R. The increasing mortality attributed to cirrhosis and fatty liver, in Baltimore (1957-1966). Ann Intern Med. 1968 8; 69(2):273\u201382. PMID: 5667768. https:\/\/doi.org\/10.7326\/0003-4819-69-2-273.","DOI":"10.7326\/0003-4819-69-2-273"},{"key":"bibr56-1925362118782061","doi-asserted-by":"crossref","unstructured":"Clark JC. Sudden death in the chronic alcoholic. Forensic Sci Int. 1988 1; 36(1-2):105\u201311. PMID: 3338681. https:\/\/doi.org\/10.1016\/0379-0738(88)90222-8.","DOI":"10.1016\/0379-0738(88)90222-8"},{"key":"bibr57-1925362118782061","doi-asserted-by":"crossref","unstructured":"Milroy C. Sudden death and chronic alcoholism. Acad Forensic Pathol. 2014 6, 4(2):168\u201371. https:\/\/doi.org\/10.23907\/2014.027.","DOI":"10.23907\/2014.027"},{"key":"bibr58-1925362118782061","doi-asserted-by":"crossref","unstructured":"Targher G, Valbusa F, Bonapace S, Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2014 6; 24(6):663\u20139. PMID: 24594085. https:\/\/doi.org\/10.1016\/j.numecd.2014.01.005.","DOI":"10.1016\/j.numecd.2014.01.005"},{"key":"bibr59-1925362118782061","doi-asserted-by":"crossref","unstructured":"Ballestri S, Lonardo A, Bonapace S, Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol. 2014 2 21; 20(7):1724\u201345. PMID: 24587651. PMCID: PMC3930972. https:\/\/doi.org\/10.3748\/wjg.v20.i7.1724.","DOI":"10.3748\/wjg.v20.i7.1724"},{"key":"bibr60-1925362118782061","doi-asserted-by":"crossref","unstructured":"Mantovani A, Rigamonti A, Bonapace S, Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour Holter monitoring. Diabetes Care. 2016 8; 39(8):1416\u201323. PMID: 27222503. https:\/\/doi.org\/10.2337\/dc16-0091.","DOI":"10.2337\/dc16-0091"},{"key":"bibr61-1925362118782061","doi-asserted-by":"crossref","unstructured":"Mantovani A, Ballestri S, Lonardo A, Targher G. Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease. Dig Dis Sci. 2016 8; 61(5):1246\u201367. PMID: 26809873. https:\/\/doi.org\/10.1007\/s10620-016-4040-6.","DOI":"10.1007\/s10620-016-4040-6"},{"key":"bibr62-1925362118782061","doi-asserted-by":"crossref","unstructured":"Byrne CD., Targher G. NAFLD: a multisystem disease. J Hepatol. 2015 4; 62(1 Suppl): S47\u201364. PMID: 25920090. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012.","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"bibr63-1925362118782061","doi-asserted-by":"crossref","unstructured":"Schwimmer JB, Deutsch R, Kahen T, Prevalence of fatty liver in children and adolescents. Pediatrics. 2006 10; 118(4):1388\u201393. PMID: 17015527. https:\/\/doi.org\/10.1542\/peds.2006-1212.","DOI":"10.1542\/peds.2006-1212"},{"key":"bibr64-1925362118782061","doi-asserted-by":"crossref","unstructured":"Tominaga K, Kurata JH, Chen YK, Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci. 1995 9; 40(9):2002\u20139. PMID: 7555456. https:\/\/doi.org\/10.1007\/bf02208670.","DOI":"10.1007\/BF02208670"},{"key":"bibr65-1925362118782061","doi-asserted-by":"crossref","unstructured":"Schwimmer JB, Behling C, Newbury R, Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005 9; 42(3):641\u20139. PMID: 16116629. https:\/\/doi.org\/10.1002\/hep.20842.","DOI":"10.1002\/hep.20842"},{"key":"bibr66-1925362118782061","doi-asserted-by":"crossref","unstructured":"Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, The natural history of nonalcoholic fatty liver disease in children. a follow-up study for up to 20 years. Gut. 2009 11; 58(11):1538\u201344. PMID: 19625277. PMCID: PMC2792743. https:\/\/doi.org\/10.1136\/gut.2008.171280.","DOI":"10.1136\/gut.2008.171280"},{"key":"bibr67-1925362118782061","doi-asserted-by":"crossref","unstructured":"Howat AJ, Bennett MJ, Variend S, Shaw L. Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome. Br Med J (Clin Res Ed). 1984 3 31; 288(6422):976. PMID: 6423169. PMCID: PMC1442514. https:\/\/doi.org\/10.1136\/bmj.288.6422.976.","DOI":"10.1136\/bmj.288.6422.976"},{"key":"bibr68-1925362118782061","doi-asserted-by":"crossref","unstructured":"Bonnell HJ, Beckwith JB. Fatty liver in sudden childhood death. Implications for Reye\u2019s Syndrome? Am J Dis Child. 1986 1; 140(1):30\u20133. PMID: 3942104. https:\/\/doi.org\/10.1001\/archpedi.1986.02140150032027.","DOI":"10.1001\/archpedi.1986.02140150032027"},{"issue":"11","key":"bibr69-1925362118782061","first-page":"11","volume":"45","author":"Berry PJ","year":"1992","journal-title":"J Clin Pathol"}],"container-title":["Academic Forensic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1925362118782061","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1925362118782061","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1925362118782061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:53:09Z","timestamp":1777366389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1925362118782061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1177\/1925362118782061"],"URL":"https:\/\/doi.org\/10.1177\/1925362118782061","relation":{},"ISSN":["1925-3621","1925-3621"],"issn-type":[{"value":"1925-3621","type":"print"},{"value":"1925-3621","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}